PRN: Global Glaucoma Partnering Deals and Agreements Entered Into by the World's Leading Healthcare Companies 2010-2017 - Research and Markets
07/mar/2017 13:15:09 PR Newswire Turismo Contatta l'autore
Global Glaucoma Partnering Deals and Agreements Entered Into by the World's Leading Healthcare Companies 2010-2017 - Research and Markets |
[07-March-2017] |
DUBLIN, Mar. 7, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Glaucoma Partnering 2010 to 2017" report to their offering. The Global Glaucoma Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight. Global Glaucoma Therapy Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits: - In-depth understanding of deal trends since 2010 Key Topics Covered: Executive Summary Media Contact: Laura Wood, Senior Manager  |